ATE328583T1 - Hochdosierte liposomale aerosolformulierung - Google Patents

Hochdosierte liposomale aerosolformulierung

Info

Publication number
ATE328583T1
ATE328583T1 AT04009645T AT04009645T ATE328583T1 AT E328583 T1 ATE328583 T1 AT E328583T1 AT 04009645 T AT04009645 T AT 04009645T AT 04009645 T AT04009645 T AT 04009645T AT E328583 T1 ATE328583 T1 AT E328583T1
Authority
AT
Austria
Prior art keywords
high dose
compounds
phospholipid
aerosol composition
liposome aerosol
Prior art date
Application number
AT04009645T
Other languages
German (de)
English (en)
Inventor
Clifford J Waldrep
Vernon Knight
Melanie B Black
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/731,605 external-priority patent/US5958378A/en
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Application granted granted Critical
Publication of ATE328583T1 publication Critical patent/ATE328583T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04009645T 1996-07-03 1997-07-02 Hochdosierte liposomale aerosolformulierung ATE328583T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67565496A 1996-07-03 1996-07-03
US08/731,605 US5958378A (en) 1996-07-03 1996-10-16 High dose liposomal aerosol formulations containing cyclosporin A or budesonide

Publications (1)

Publication Number Publication Date
ATE328583T1 true ATE328583T1 (de) 2006-06-15

Family

ID=27101390

Family Applications (2)

Application Number Title Priority Date Filing Date
AT04009645T ATE328583T1 (de) 1996-07-03 1997-07-02 Hochdosierte liposomale aerosolformulierung
AT97933287T ATE268163T1 (de) 1996-07-03 1997-07-02 Hochdosierte liposomale aerosolformulierung

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT97933287T ATE268163T1 (de) 1996-07-03 1997-07-02 Hochdosierte liposomale aerosolformulierung

Country Status (10)

Country Link
EP (1) EP0959874B1 (enExample)
JP (1) JP2001524930A (enExample)
CN (1) CN1094345C (enExample)
AT (2) ATE328583T1 (enExample)
AU (1) AU732124B2 (enExample)
CA (1) CA2259185C (enExample)
DE (2) DE69729391T2 (enExample)
NZ (1) NZ333497A (enExample)
TW (1) TW497974B (enExample)
WO (1) WO1998000111A1 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6417172B1 (en) * 1995-06-05 2002-07-09 Eisai Co., Ltd. Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs
US5863910A (en) * 1996-01-12 1999-01-26 Bolonick; Joel Treatment of chronic inflammatory disorders of the gastrointestinal tract
US6090407A (en) 1997-09-23 2000-07-18 Research Development Foundation Small particle liposome aerosols for delivery of anti-cancer drugs
US7348025B2 (en) 1997-09-23 2008-03-25 Research Development Foundation Small particle liposome aerosols for delivery of anticancer drugs
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US20020006901A1 (en) * 1999-02-05 2002-01-17 Aldo T. Iacono Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
WO2000074653A1 (en) * 1999-06-04 2000-12-14 Skyepharma, Inc. Oil-core compositions for the sustained release of hydrophobic drugs
JP2003515568A (ja) * 1999-12-04 2003-05-07 リサーチ ディベロップメント ファンデーション 吸入療法における二酸化炭素増強
CA2382133C (en) 2000-05-10 2010-11-23 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
EP1458360B1 (en) 2001-12-19 2011-05-11 Novartis AG Pulmonary delivery of aminoglycosides
CA2486622A1 (en) * 2002-05-20 2003-12-04 Research Development Foundation Aerosol drug inhibition of lung metastases
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
AU2006256518B2 (en) * 2005-06-09 2012-03-15 Meda Ab Method and composition for treating inflammatory disorders
DE102006051512A1 (de) * 2005-12-06 2007-06-14 Pari GmbH Spezialisten für effektive Inhalation Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin
CN101502484B (zh) * 2006-12-26 2011-04-20 济南康泉医药科技有限公司 同载糖皮质激素和化疗药物的抗癌缓释剂
EP2207527A2 (en) * 2007-11-09 2010-07-21 MAP Pharmaceuticals Inc Methods for administering corticosteroid formulations
PE20130045A1 (es) 2010-03-12 2013-01-28 Berg Pharma Llc FORMULACIONES INTRAVENOSAS DE COENZIMA Q10 (CoQ10) Y METODOS DE USO DE LAS MISMAS
US20120028335A1 (en) 2010-07-28 2012-02-02 Life Technologies Corporation Anti-viral azide-containing compounds
US20130209550A1 (en) 2010-07-28 2013-08-15 Life Technologies Corporation Anti-Viral Azide Containing Compounds
AU2011287205A1 (en) * 2010-08-05 2013-03-07 Piramal Enterprises Limited Microparticle formulation for pulmonary drug delivery of anti-infective molecule for treatment of infectious diseases
CN102008713B (zh) * 2010-12-02 2012-10-24 深圳海王药业有限公司 环孢素a前体脂质体、药物组合物及其制备方法
CN103732214B (zh) * 2011-06-17 2017-04-12 博格有限责任公司 可吸入药物组合物
GB201114332D0 (en) 2011-08-19 2011-10-05 Nufarm Uk Ltd Novel inhibitor compositions and methods of use
WO2013112780A1 (en) 2012-01-26 2013-08-01 Life Technologies Corporation Methods for increasing the infectivity of viruses
CN113038930A (zh) * 2018-06-27 2021-06-25 呼吸治疗公司 冻干形式的药物组合物
JP7526103B2 (ja) * 2018-06-27 2024-07-31 ブレス テラポイティクス ゲーエムベーハー 大環状免疫抑制剤を含む吸入用組成物
EA202092892A1 (ru) 2018-12-04 2021-05-27 Брес Терапьютикс Гмбх Ингаляционные композиции, содержащие макроциклические иммуносупрессанты

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8403905D0 (sv) * 1984-07-30 1984-07-30 Draco Ab Liposomes and steroid esters
SE8603812D0 (sv) * 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
IE63869B1 (en) * 1986-11-06 1995-06-14 Res Dev Foundation Aerosols containing liposomes and method for their preparation
US5049388A (en) * 1986-11-06 1991-09-17 Research Development Foundation Small particle aerosol liposome and liposome-drug combinations for medical use
US4906476A (en) * 1988-12-14 1990-03-06 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs in lungs
MX9201782A (es) * 1991-04-19 1992-10-01 Sandoz Ag Particulas de sustancias biologicamente activas, sustancialmente insolubles en agua, proceso para su produccion y composicion farmaceutica que las contiene.
DE4203306A1 (de) * 1992-02-06 1993-08-12 Ig Spruehtechnik Gmbh Asthma oder pulmonal-aerosolzubereitungen mit lecithin
AR002009A1 (es) * 1994-12-22 1998-01-07 Astra Ab Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.

Also Published As

Publication number Publication date
AU732124B2 (en) 2001-04-12
EP0959874B1 (en) 2004-06-02
CN1224347A (zh) 1999-07-28
DE69736083D1 (de) 2006-07-20
TW497974B (en) 2002-08-11
DE69729391D1 (de) 2004-07-08
DE69729391T2 (de) 2005-06-02
CA2259185A1 (en) 1998-01-08
NZ333497A (en) 2000-06-23
EP0959874A4 (enExample) 1999-12-22
AU3650897A (en) 1998-01-21
WO1998000111A1 (en) 1998-01-08
CA2259185C (en) 2009-12-15
ATE268163T1 (de) 2004-06-15
CN1094345C (zh) 2002-11-20
DE69736083T2 (de) 2006-12-28
JP2001524930A (ja) 2001-12-04
EP0959874A1 (en) 1999-12-01

Similar Documents

Publication Publication Date Title
ATE328583T1 (de) Hochdosierte liposomale aerosolformulierung
CA1223819A (en) Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
UA29469C2 (uk) Ліпосомальна фармацевтична композиція для внутрішньовенного введення
BR0114713A (pt) Formulação lipossÈmica de mitoxantrona
NZ509418A (en) Pharmaceutical formulations for aerosols with two or more active substances
NO944957L (no) Galenisk blanding, fremgangsmåte for fremstilling av denne, samt anvendelse derav
ES2038643T3 (es) Procedimiento para la obtencion de una composicion farmaceutica topica.
CA2033725A1 (en) Pharmaceutical and cosmetic compositions containing a salt of cholanic acid
IL91656A0 (en) Pharmaceutical composition containing a benzodiazepine derivative
WO1998058629A3 (en) Preparation of pharmaceutical compositions
CA2156288A1 (en) Glycerol derivative, device and pharmaceutical composition
CA2301017A1 (en) Use of propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
ES2157307T3 (es) Composicion topica que contiene un antagonista de sustancia p.
ATE324907T1 (de) Verbindung und arzneizusammensetzung zur verabreichung von wirkstoffen
ATE554750T1 (de) Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen
BR9912694A (pt) Composto para preparar medicamento de administração pulmonar
WO1998013024A3 (en) Hyaluronic drug delivery system
KR960028918A (ko) 국소용 약제학적 조성물
IL117889A0 (en) Pharmaceutical compositions containing lipophilic compounds
DE69939180D1 (de) Pharmazeutische zubereitungen zur externen anwendung, die nicht steroidale antiinflammatorische und analgetische wirkstoffe enthalten
NZ506429A (en) Erythropoietin liposomal dispersion
KR960700061A (ko) 니코틴 의존상태 치료를 위한 약리학적 제형 (pharmaceutical composition for treating nicotine dependence)
ITMI921831A1 (it) Composizioni farmaceutiche in forma di microemulsioni o di dispersioni liposomiali bioadesive per la somministrazione transmucosale di sostanze peptidiche e di proteine farmacologicamente attive
SE9403389D0 (sv) Pharmaceutical composition containing derivattves of sex hormones
IT1260155B (it) Uso terapeutico della fosforil-l-serina-n-acil-sfingosina

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties